Neonatal seizures and hypoxic-ischaemic encephalopathy (HIE) represent critical neurological conditions with profound implications for early brain development and long-term neurodevelopmental outcomes ...

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal hypoxic-ischemic encephalopathy (HIE), which affects one to three in 1,000 live ...

Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with neonatal hypoxic ischemic encephalopathy (HIE), a phase III randomized trial ...

What do you do when a child is born with poor consciousness, not crying, not sucking, and not breathing on their own? For babies born with hypoxic-ischemic encephalopathy, commonly called birth ...

Please provide your email address to receive an email when new articles are posted on . High-dose erythropoietin did not improve outcomes for infants with hypoxic ischemic encephalopathy. Controlled ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby’s body temperature—called therapeutic hypothermia—is often used ...

Between December 2024 and February 2025, 10 newborns with hypoxic-ischemic brain injury were treated with breast milk administered through the nasal passages using a special method at Semmelweis ...

A key goal of neonatal neurocritical care is improved outcomes, and brain monitoring plays an essential role. The recent NEST trial 1 reported no outcome benefits using aEEG monitoring compared to ...